Human exercise-induced circulating progenitor cell mobilization is nitric oxide-dependent and is blunted in South Asian men. 2010

Richard M Cubbon, and Scott R Murgatroyd, and Carrie Ferguson, and T Scott Bowen, and Mark Rakobowchuk, and Vivek Baliga, and Daniel Cannon, and Adil Rajwani, and Afroze Abbas, and Matthew Kahn, and Karen M Birch, and Karen E Porter, and Stephen B Wheatcroft, and Harry B Rossiter, and Mark T Kearney
Division of Cardiovascular and Diabetes Research, Leeds Multidisciplinary Cardiovascular Research Centre, LIGHT Laboratories, Clarendon Way, The University of Leeds, Leeds, LS2 9JT, United Kingdom.

OBJECTIVE Circulating progenitor cells (CPC) have emerged as potential mediators of vascular repair. In experimental models, CPC mobilization is critically dependent on nitric oxide (NO). South Asian ethnicity is associated with reduced CPC. We assessed CPC mobilization in response to exercise in Asian men and examined the role of NO in CPC mobilization per se. RESULTS In 15 healthy, white European men and 15 matched South Asian men, CPC mobilization was assessed during moderate-intensity exercise. Brachial artery flow-mediated vasodilatation was used to assess NO bioavailability. To determine the role of NO in CPC mobilization, identical exercise studies were performed during intravenous separate infusions of saline, the NO synthase inhibitor L-NMMA, and norepinephrine. Flow-mediated vasodilatation (5.8%+/-0.4% vs 7.9%+/-0.5%; P=0.002) and CPC mobilization (CD34(+)/KDR(+) 53.2% vs 85.4%; P=0.001; CD133(+)/CD34(+)/KDR(+) 48.4% vs 73.9%; P=0.05; and CD34(+)/CD45(-) 49.3% vs 78.4; P=0.006) was blunted in the South Asian group. CPC mobilization correlated with flow-mediated vasodilatation and l-NMMA significantly reduced exercise-induced CPC mobilization (CD34(+)/KDR(+) -3.3% vs 68.4%; CD133(+)/CD34(+)/KDR(+) 0.7% vs 71.4%; and CD34(+)/CD45(-) -30.5% vs 77.8%; all P<0.001). CONCLUSIONS In humans, NO is critical for CPC mobilization in response to exercise. Reduced NO bioavailability may contribute to imbalance between vascular damage and repair mechanisms in South Asian men.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001916 Brachial Artery The continuation of the axillary artery; it branches into the radial and ulnar arteries. Arteries, Brachial,Artery, Brachial,Brachial Arteries
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated

Related Publications

Richard M Cubbon, and Scott R Murgatroyd, and Carrie Ferguson, and T Scott Bowen, and Mark Rakobowchuk, and Vivek Baliga, and Daniel Cannon, and Adil Rajwani, and Afroze Abbas, and Matthew Kahn, and Karen M Birch, and Karen E Porter, and Stephen B Wheatcroft, and Harry B Rossiter, and Mark T Kearney
March 2017, Journal of applied physiology (Bethesda, Md. : 1985),
Richard M Cubbon, and Scott R Murgatroyd, and Carrie Ferguson, and T Scott Bowen, and Mark Rakobowchuk, and Vivek Baliga, and Daniel Cannon, and Adil Rajwani, and Afroze Abbas, and Matthew Kahn, and Karen M Birch, and Karen E Porter, and Stephen B Wheatcroft, and Harry B Rossiter, and Mark T Kearney
December 2009, Journal of applied physiology (Bethesda, Md. : 1985),
Richard M Cubbon, and Scott R Murgatroyd, and Carrie Ferguson, and T Scott Bowen, and Mark Rakobowchuk, and Vivek Baliga, and Daniel Cannon, and Adil Rajwani, and Afroze Abbas, and Matthew Kahn, and Karen M Birch, and Karen E Porter, and Stephen B Wheatcroft, and Harry B Rossiter, and Mark T Kearney
August 2008, Peptides,
Richard M Cubbon, and Scott R Murgatroyd, and Carrie Ferguson, and T Scott Bowen, and Mark Rakobowchuk, and Vivek Baliga, and Daniel Cannon, and Adil Rajwani, and Afroze Abbas, and Matthew Kahn, and Karen M Birch, and Karen E Porter, and Stephen B Wheatcroft, and Harry B Rossiter, and Mark T Kearney
March 2012, Human reproduction (Oxford, England),
Richard M Cubbon, and Scott R Murgatroyd, and Carrie Ferguson, and T Scott Bowen, and Mark Rakobowchuk, and Vivek Baliga, and Daniel Cannon, and Adil Rajwani, and Afroze Abbas, and Matthew Kahn, and Karen M Birch, and Karen E Porter, and Stephen B Wheatcroft, and Harry B Rossiter, and Mark T Kearney
April 2007, Arteriosclerosis, thrombosis, and vascular biology,
Richard M Cubbon, and Scott R Murgatroyd, and Carrie Ferguson, and T Scott Bowen, and Mark Rakobowchuk, and Vivek Baliga, and Daniel Cannon, and Adil Rajwani, and Afroze Abbas, and Matthew Kahn, and Karen M Birch, and Karen E Porter, and Stephen B Wheatcroft, and Harry B Rossiter, and Mark T Kearney
January 2007, Handbook of experimental pharmacology,
Richard M Cubbon, and Scott R Murgatroyd, and Carrie Ferguson, and T Scott Bowen, and Mark Rakobowchuk, and Vivek Baliga, and Daniel Cannon, and Adil Rajwani, and Afroze Abbas, and Matthew Kahn, and Karen M Birch, and Karen E Porter, and Stephen B Wheatcroft, and Harry B Rossiter, and Mark T Kearney
June 2007, Journal of human hypertension,
Richard M Cubbon, and Scott R Murgatroyd, and Carrie Ferguson, and T Scott Bowen, and Mark Rakobowchuk, and Vivek Baliga, and Daniel Cannon, and Adil Rajwani, and Afroze Abbas, and Matthew Kahn, and Karen M Birch, and Karen E Porter, and Stephen B Wheatcroft, and Harry B Rossiter, and Mark T Kearney
January 2007, Journal of cardiopulmonary rehabilitation and prevention,
Richard M Cubbon, and Scott R Murgatroyd, and Carrie Ferguson, and T Scott Bowen, and Mark Rakobowchuk, and Vivek Baliga, and Daniel Cannon, and Adil Rajwani, and Afroze Abbas, and Matthew Kahn, and Karen M Birch, and Karen E Porter, and Stephen B Wheatcroft, and Harry B Rossiter, and Mark T Kearney
March 2007, Diabetes,
Richard M Cubbon, and Scott R Murgatroyd, and Carrie Ferguson, and T Scott Bowen, and Mark Rakobowchuk, and Vivek Baliga, and Daniel Cannon, and Adil Rajwani, and Afroze Abbas, and Matthew Kahn, and Karen M Birch, and Karen E Porter, and Stephen B Wheatcroft, and Harry B Rossiter, and Mark T Kearney
July 2016, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!